AUTHORS ' CONCLUSIONS Addition of ox and rolone to the GH therapy led to a modest increase in the final adult height of girls aged up to 18 years with TS .
BACKGROUND The final adult height of untreated girls aged up to 18 years with Turner syndrome ( TS ) is approximately 20 cm shorter compared with healthy females .
Treatment with growth hormone ( GH ) increases the adult height of people with TS .
The effects of adding the and rogen , ox and rolone , in addition to GH are unclear .
Therefore , we conducted this systematic review to investigate the benefits and harms of ox and rolone as an adjuvant therapy for people with TS treated with GH .
OBJECTIVES To assess the effects of ox and rolone on growth hormone-treated girls aged up to 18 years with Turner syndrome .
Chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in Århus, Denmark
Summary As part of a larger prospect i ve study of the influence of environmental factors on pregnancy , birth and the fetus , chromosome examinations have been made in 34910 newborn children in Århus over a 13-year period . Klinefelter 's syndrome was found in 1 per 576 boys , XYY in 1 per 851 boys , triple-X in 1 per 947 girls and Turner 's syndrome in 1 per 1893 girls . Other sex chromosome aberrations were found in 1 per 11637 children . The total incidence of sex chromosome abnormalities was 1 per 426 children or 2.34 per 1000 . The most frequent autosomal abnormalities were that of Down 's syndrome with 1 per 592 children , and reciprocal translocations with 1 per 712 children . The total incidence of autosomal abnormalities was 1 per 164 children . Chromosome abnormalities were found in 276 liveborn children and in 19 fetuses , who were aborted after prenatal chromosome examination . The combined incidence of sex chromosomal and autosomal abnormalities was 1 per 118 children or 8.45 per 1000 children
AUTHORS ' CONCLUSIONS Addition of ox and rolone to the GH therapy led to a modest increase in the final adult height of girls aged up to 18 years with TS .
BACKGROUND The final adult height of untreated girls aged up to 18 years with Turner syndrome ( TS ) is approximately 20 cm shorter compared with healthy females .
Treatment with growth hormone ( GH ) increases the adult height of people with TS .
The effects of adding the and rogen , ox and rolone , in addition to GH are unclear .
Therefore , we conducted this systematic review to investigate the benefits and harms of ox and rolone as an adjuvant therapy for people with TS treated with GH .
OBJECTIVES To assess the effects of ox and rolone on growth hormone-treated girls aged up to 18 years with Turner syndrome .